13D/13G Filings - Life Sciences Alternative Funding LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-13
07:30 am
Sale
2024-09-30 13G Biodesix, Inc.
BDSX
Life Sciences Alternative Funding LLC 2,180,514
1.500%
-9,913decrease
(-0.45%)
Filing
History
2021-05-28
6:03 pm
Purchase
2020-12-31 13G Biodesix, Inc.
BDSX
Life Sciences Alternative Funding LLC 2,190,427
8.200%
2,190,427increase
(New Position)
Filing
History